Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,740 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Postazacitidine clone size predicts long-term outcome of patients with myelodysplastic syndromes and related myeloid neoplasms.
Nannya Y, Tobiasson M, Sato S, Bernard E, Ohtake S, Takeda J, Creignou M, Zhao L, Kusakabe M, Shibata Y, Nakamura N, Watanabe M, Hiramoto N, Shiozawa Y, Shiraishi Y, Tanaka H, Yoshida K, Kakiuchi N, Makishima H, Nakagawa M, Usuki K, Watanabe M, Imada K, Handa H, Taguchi M, Kiguchi T, Ohyashiki K, Ishikawa T, Takaori-Kondo A, Tsurumi H, Kasahara S, Chiba S, Naoe T, Miyano S, Papaemanuil E, Miyazaki Y, Hellström-Lindberg E, Ogawa S. Nannya Y, et al. Among authors: nakamura n. Blood Adv. 2023 Jul 25;7(14):3624-3636. doi: 10.1182/bloodadvances.2022009564. Blood Adv. 2023. PMID: 36989067 Free PMC article.
Lenalidomide-induced cytokine release syndrome in a patient with multiple myeloma.
Nakamura N, Kanemura N, Shibata Y, Matsumoto T, Mabuchi R, Nakamura H, Kitagawa J, Goto N, Hara T, Tsurumi H, Moriwaki H. Nakamura N, et al. Among authors: nakamura h. Leuk Lymphoma. 2014 Jul;55(7):1691-3. doi: 10.3109/10428194.2013.853300. Epub 2014 Jan 28. Leuk Lymphoma. 2014. PMID: 24138307 No abstract available.
Serum soluble tumor necrosis factor receptor 1 level is associated with the outcome of diffuse large B-cell lymphoma patients treated with the CHOP or R-CHOP regimen.
Goto N, Tsurumi H, Takemura M, Matsumoto T, Shibata Y, Mabuchi R, Nakamura N, Nakamura H, Yamada T, Seishima M, Takami T, Takeuchi T, Moriwaki H. Goto N, et al. Among authors: nakamura n, nakamura h. J Clin Exp Hematop. 2014;54(2):117-27. doi: 10.3960/jslrt.54.117. J Clin Exp Hematop. 2014. PMID: 25318944 Free article. No abstract available.
CHOP or THP-COP regimens in the treatment of newly diagnosed peripheral T-cell lymphoma, not otherwise specified: a comparison of doxorubicin and pirarubicin.
Shibata Y, Hara T, Kasahara S, Yamada T, Sawada M, Mabuchi R, Matsumoto T, Nakamura N, Nakamura H, Ninomiya S, Kitagawa J, Kanemura N, Kito Y, Goto N, Miyazaki T, Takami T, Takeuchi T, Shimizu M, Tsurumi H. Shibata Y, et al. Among authors: nakamura n, nakamura h. Hematol Oncol. 2017 Jun;35(2):163-171. doi: 10.1002/hon.2262. Epub 2015 Oct 9. Hematol Oncol. 2017. PMID: 26449182
3,740 results